| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2018 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14,3 M € | +19.6% | 12,0 M € | +4.8% | 11,4 M € | +1.7% | 11,2 M € | +18.4% | 9,5 M € | +38.1% | 6,9 M € | +378.0% | 1,4 M € | |
| EBITDA | -2,0 M € | -86.0% | -1,1 M € | +33.1% | -1,6 M € | -240.2% | -478,8 k € | +31.3% | -697,2 k € | -20.9% | -576,5 k € | +2.4% | -590,4 k € | |
| Operating profit | -2,0 M € | -80.2% | -1,1 M € | +30.2% | -1,6 M € | -813.3% | -178,4 k € | +82.1% | -997,6 k € | -73.1% | -576,5 k € | +2.4% | -590,4 k € | |
| Profit/loss | 11,6 M € | +295.5% | -5,9 M € | -197.8% | -2,0 M € | -239.5% | 1,4 M € | +109.7% | -14,8 M € | -1453.9% | 1,1 M € | +390.3% | -375,2 k € | |
| Equity | 153,7 M € | +25.4% | 122,6 M € | -4.6% | 128,5 M € | -1.5% | 130,5 M € | +8.7% | 120,0 M € | +40.6% | 85,4 M € | +170.5% | 31,6 M € | |
| Total assets | 283,8 M € | +11.8% | 253,9 M € | -6.1% | 270,3 M € | -1.6% | 274,8 M € | +11.3% | 246,9 M € | +66.5% | 148,3 M € | +136.9% | 62,6 M € | |
| Cash | 8,2 € | -91.0% | 91,2 € | -100.0% | 6,4 M € | -20.0% | 8,0 M € | +127.1% | 3,5 M € | +542.4% | 549,0 k € | -13.4% | 633,8 k € | |
| Debts | 127,3 M € | -1.7% | 129,4 M € | -5.9% | 137,5 M € | -3.1% | 141,8 M € | +12.1% | 126,5 M € | +101.0% | 62,9 M € | +102.8% | 31,0 M € | |
Public limited company · Wevelgem · incorporated on 12/12/2017
Public limited company profitable and well capitalised. Cash position declining (-91.0%).
Solid counterparty for a standard engagement.
VISION HEALTHCARE is a Public limited company incorporated in 2017. Its main activity is: Manufacture of pharmaceutical preparations. Its registered office is in Wevelgem.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette